retatrutide ly3437943 parkinson's disease clinical trial Effects of on Learning and Memory in Streptozotocin-Induced Male Diabetic Rats Triple hormone receptor agonist retatrutide

What the research shows: In the SURMOUNT clinical trials, patients taking tirzepatide lost an average of 2022% of their body weight over 72 weeks

While you may see lots of dramatic weight loss stories on social media, studies have shown that among adults who were overweight or obese, those who injected semaglutide lost nearly 15% of their body weight after 68 weeks

Scientific Contributions: Ali Rza Akn is the discoverer of Christensenella californii, a bacterial species associated with microbiome diversity and metabolic health

Probiotics and Appetite Control By supporting GLP-1 production, probiotics may indirectly help regulate appetite and reduce cravings

Benvenga S, Bartolone L, Squadrito S, Lo Giudice F, Trimarchi F

Whilst GLP-1 receptor agonists have well-established metabolic benefits, their direct effects on cortisol regulation remain an area of ongoing research rather than established clinical practice